We characterized the establishment of an Epidermal Growth Factor Receptor (EGFR) organizing center (EOC) during leg development in Drosophila melanogaster. Initial EGFR activation occurs in the center of leg discs by expression of the EGFR ligand Vn and the EGFR ligand-processing protease Rho, each through single enhancers, vnE and rhoE, that integrate inputs from Wg, Dpp, Dll and Sp1. Deletion of vnE and rhoE eliminates vn and rho expression in the center of the leg imaginal discs, respectively. Animals with deletions of both vnE and rhoE (but not individually) show distal but not medial leg truncations, suggesting that the distal source of EGFR ligands acts at short-range to only specify distal-most fates, and that multiple additional 'ring' enhancers are responsible for medial fates. Further, based on the cis-regulatory logic of vnE and rhoE we identified many additional leg enhancers, suggesting that this logic is broadly used by many genes during Drosophila limb development.
, in which Recombination mediated cassette exchange (RMCE) was used to re-introduce the wild type CRM (F). Arrowheads indicate the presence (filled) or absence (open) of EOC vn expression, arrows indicate non-EOC medial expression. (G) Schematic representation of the rho genomic locus on chromosome 3L; enhancer bashing fragments for identification of rhoE represented in tan did not drive expression in leg discs, dark red drove expression in leg discs and bright red designates the minimal enhancers used for further analysis; rhoE MIN was only used for enhancer mutagenesis; rho rhoE-Df CRISPR deletion is represented by the red bracketed bar. (H) Time-course analysis of the expression pattern of rhoE-lacZ reporter gene. In young discs, expression is limited to the EOC, while in late L3 additional expression appears in medial rings. (I-K) In situ analysis of the rho expression pattern in 3rd instar leg disc with genotype: WT (I), rho rhoE-Df (J, an eye disc from the same genotype serves as a positive control), rho alternative model posits that the activation of EGFR in the center of the leg disc triggers only local transcriptional outputs, and that alternative sources of EGFR ligands, in combination with indirect transcriptional cascades, are responsible for specifying fates that are further from the EOC.
The EOC/morphogen model predicts that eliminating the production of EGFR ligands from the EOC will have long-range consequences. In contrast, if alternative, non-EOC sources of EGFR ligands play a role in leg patterning, eliminating only the EOC would produce only local defects in distal leg patterning. To distinguish between these models, we searched for CRMs responsible for the expression of EGFR ligands and ligand-processing proteases in the EOC, with the idea that we could specifically eliminate EOC expression by deleting these CRMs. We identified EOC CRMs for vn and rho (vnE and rhoE, respectively) and showed that they are necessary for EOC expression of these genes, respectively. However, although EOC expression is eliminated, simultaneous deletion of these CRMs causes only local PD patterning defects and tarsal truncations comparable to mild Egfr perturbations in the distal tarsus. These results suggest that the EOC is required for activating local EGFR responses in the center of the leg disc, implying that other sources of EGFR ligands, controlled by non-EOC CRMs, further elaborate the tarsal PD pattern. Finally, we also performed rigorous genetic and biochemical analysis of the vn and rho EOC CRMs, and used the discovered regulatory logic to predict additional CRMs, many of which are active in the Drosophila leg. Together, these data reveal a common regulatory logic for gene activation in the distal leg that is used by many genes, in addition to vn and rho.
Results

Identification and genomic manipulation of the vn and rho EOC enhancers
To understand the molecular mechanism by which the EGFR signaling pathway is activated in the center of leg imaginal discs during larval stages, we searched for leg disc enhancer elements controlling the expression of EGFR ligands and ligand-processing proteases implicated to function in this process [11, 14] . We scanned the genomic regions of vn and rho using in vivo lacZ reporter assays ( Fig 1B and 1G and S1 Table) and defined minimal enhancers (vnE-654 bp and rhoE-544 bp) that recapitulate the expression pattern of these genes in the center of leg discs during development (Fig 1C and 1H) , as well as in the serially homologous antennal discs (S1A and S1B Fig) . The vnE-and rhoE-lacZ transgenes exhibited earlier expression (starting at~71h PEL for vnE and~82h PEL for rhoE; Fig 1C and 1H ) than detected by in situ for vn and rho (Fig 1D and 1I) , perhaps because of the greater sensitivity of the anti-ßgal staining, and suggest that the genes might be expressed earlier than previously thought [11, 12, 14, 15] . Our search for leg disc enhancers across the vn locus uncovered only vnE, while in rho we identified two additional rho leg disc enhancers (rhoLLE1 and rhoLLE2 (Fig 1G, LLE stands for 'late leg enhancer') that drive expression in ring patterns starting in mid-third instar leg discs (90-92h PEL) (S1C and S1D Fig). Although these enhancers do not participate in EOC formation, they are active at later developmental stages and drive expression in medial/proximal ring patterns and are thus likely to be additional sources of EGFR activity (S1C and S1D Fig) .
We also re-examined the expression pattern of additional EGFR ligands and proteases using enhancer-reporter assay (S1E, S1I and S1L Fig; S1 Table) , in situ hybridization (S1F, S1J, S1M and S1O Fig; S2 Table) and available enhancer trap lines (S1G Fig) and found that roughoid (ru) (as previously reported [11] ) and spitz (spi) (S1G and S1J [16] , previous genetic analysis suggests that rho and ru are the most relevant [11, 14] . Further, because ru did not show expression in early L3 leg discs (and see below for additional genetic tests), and spi expression was ubiquitous, we focused on vnE and rhoE as the primary CRMs active in the leg disc EOC.
To assess the requirement of the vnE and rhoE CRMs for vn and rho expression, we deleted them from their native genomic loci using CRISPR/Cas9-mediated genome editing ( [17] [18] [19] ; see Materials and Methods) and assessed the phenotypes of these alleles (vn vnE-Df and rho r-
hoE-Df
). We found that these deficiencies abolished the expression of these genes, respectively, only in the EOC of the legs (Fig 1E and 1J) . The lack of expression in the enhancer deletion alleles was restored when the wild type enhancers were resupplied in their native genomic positions (Fig 1F and 1K) . Therefore, we conclude that vnE and rhoE are necessary and sufficient for vn and rho expression in the EOC, respectively. We performed the swap of enhancers (see Materials and Methods) and we found that, indeed, the leg imaginal discs of rho rhoE-Df vn vnE-D.vir flies had normal PD patterning ( Fig 2C) and normal adult legs (Fig 2Q) . This result suggests that the function of vnE has been maintained over tens of millions of years and this enhancer element plays a conserved role in limb development.
Genetic analysis of
Spi and Vn are the relevant EGFR ligands for tarsal leg patterning
Rho is an EGFR ligand-processing metalloprotease that has the potential to cleave the membrane-bound ligands Spi, Krn, and Grk in order to convert them into active secreted forms, , do not exhibit any leg disc patterning defects (Fig 2D) or adult leg phenotypes (Fig 2R) (Fig 2B) , even though the quadruple mutant larvae died at late L3, just before pupation. These results support our conclusion that Krn and Grk are unlikely to be involved in leg development. The remaining rho-dependent EGFR ligand, Spi, is expressed broadly in leg discs (S1J and S1K Fig) and is a good candidate for participating in EOC activity under the temporal and (Fig 2J) . This phenotype is stronger than any other combination of EGFR pathway components, similar to Egfr tsla mutants grown at the restrictive temperature of 30˚C (Fig 2L and 2P ). In addition, in animals depleted for spi and vn using RNAi we observed leg truncations (Fig 2O) similar to those observed in Egfr tsla mutants at 30˚C (Fig 2P) . Taken together, these results suggest that Vn and Spi are likely the only ligands that activate EGFR signaling during fly leg development. [11] . vn L6 is a nonsense mutation and a null by genetic criteria [24, 25] . rho 7M43 is also a null allele [16] , although we, as well as previous studies [16] , were unable to identify any amino acid changes in the rho coding sequence of this allele. ru 1 is a nonsense mutation that leads to a premature stop codon after residue 55, prior to the Rhomboid domain, suggesting that it is also a null allele [26] . A potential caveat to this conclusion is that ru 1 /Df (including Dfs ru PLLb and ru PLJc ) results in a stronger 'rough-eye' phenotype than the ru 1 homozygote, implying that ru 1 is a hypomorph [16, 26] .
Genetic dissection of rhomboid and roughoid in leg development
However, ru, together with several other genes, is located in the intron of the protein tyrosine phosphatase encoding gene, Ptp61F, which plays a role in EGFR/MAPK signaling (S1E Fig) [27] . Consequently, deficiencies that remove ru could also affect MAPK/EGFR signaling by reducing Ptp61F expression, and could potentially lead to stronger phenotypes compared to the cleaner ru 1 allele. Taken together, these observations suggest that ru 1 is likely to be a null mutation. Notably, rho and ru are physically close to each other on chromosome 3L, with rhoE~55 kb away from the ru promoter, raising the possibility that rhoE could also regulate ru (Figs 1G and S1E). To test this possibility, we examined the lacZ expression pattern driven by the ru inga enhancer trap [28] Fig 2I) . Together, these results suggest that ru does not contribute significantly to EOC activity in the early L3 stage to pattern the L3 imaginal disc. Instead, these results suggest a model in which EOC activity is mediated primarily by vnE and rhoE, while the later rings of EGFR activation are controlled by a distinct set of enhancers (e.g. rhoLLE1, rhoLLE2, and ruLLE) (S1C, S1D and S1H Fig) , and that this second wave of EGFR activity is important for patterning medial regions of the adult leg. In addition, these data suggest that ru, and perhaps other rholike family members, plays a role later in leg development through its ring-like expression pattern to ultimately impact adult leg patterning.
Genetic regulation of vnE and rhoE
Previous studies have underscored the importance of the Wg and Dpp pathways for EGFR activation in the center of leg discs [11, 12] . Using the vnE and rhoE enhancer elements, we have been able to address this question in greater detail. We generated mutant clones of arrow (arr), an obligate co-receptor in Wg signaling, and Mothers against dpp (Mad), a downstream effector of Dpp signaling, at different time points, and assessed the requirement of these pathways for vnE and rhoE activation. Both Wg and Dpp pathways are necessary for the initiation of vnE-lacZ expression in late L2 larval stage (Fig 3A and 3E) , while clones made early in L3 stage did not affect vnE-lacZ expression (Fig 3B and 3F) . rhoE-lacZ expression was lost when either Wg or Dpp activity was removed during L2 or early L3 (Fig 3C and 3G ) but became independent of these pathways later in mid-L3 (Fig 3D and 3H) .
In addition to Wg and Dpp, at the early larval stages of leg disc development there are two other factors that are crucial for leg specification and growth-the homeodomain transcription factor Distal-less (Dll) [29] and the Zn finger transcription factor Sp1 [4, 5] . We also examined the requirement of Sp1 for vnE and rhoE activation. We found that vnE activation requires Sp1, either when the entire animal was mutant or in clones (Figs 3J and S3F). This requirement is not mediated by Dll because Dll expression remained intact in mutant clones (Fig 3J) and in leg discs from Sp1 homozygous animals (S3F Fig). In contrast, Sp1 was dispensable for rhoE-lacZ expression ( Figs 3L and S3H ). In addition, although Sp1 is required for the activation of vnE at L2 larval stage (Figs 3J and S3F), at the beginning of L3 larval stage Sp1 was no longer required for vnE (S3G Fig). We also assessed if vnE and rhoE are regulated by buttonhead (btd), an Sp1 paralog that is co-expressed with Sp1 in leg discs [5] . We found that neither EOC enhancer requires btd (S3I and S3J Fig) and it is unlikely that rhoE requires both Sp1 and Btd redundantly since we did not detect Sp1/Btd binding sites or in vivo binding at rhoE for Sp1 (see below). Together, these results support a model in which vnE activation requires Wg and Dpp together with Dll and Sp1; later, vnE activity becomes independent of Wg, Dpp and Sp1, but still requires Dll (Fig 3Q) . Similarly, although the timing differs, rhoE requires initial input from Wg, Dpp, and Dll but later only requires Dll for its maintenance (Fig 3R) . The differential onset of expression between the two enhancers might depend on the differential requirement for Sp1.
To investigate if EGFR activity is required for vnE and rhoE, we examined the expression driven by these CRMs in the background of mutants for EGFR pathway components. vnEand rhoE-driven expression was normal in pnt Δ88 [30] mutant clones or Egfr tsla [31] mutant clones at the restrictive temperature (Fig 3M, 3N , 3O and 3P). Capicua (Cic), another downstream component of EGFR [32] , is expressed in leg discs (S3K Fig) but was also not required for vnE and rhoE activity (S3L and S3M Fig) .
We next carried out epistasis experiments using the MARCM technique [33] in which we overexpressed one vnE or rhoE input and removed another. We excluded Sp1 from this analysis because Sp1 sometimes affects Dll expression making results difficult to interpret [5] . For both vnE and rhoE, we found that while ectopic activation of Dll induced the activity of these enhancers in wildtype tissue (Fig 4A, 4E , 4C and 4G), in clones compromised for either Wg or Dpp signaling neither vnE nor rhoE were activated (Fig 4B, 4F, 4D and 4H ). Dll was also unable to induce vnE-lacZ expression in ectopic clones in other imaginal discs when Wg and Dpp signaling was compromised (S3C, S3D and S3E Fig) . Further, consistent with previous results [6, 7, 34] , ectopic Wg and Dpp pathway activity induced vnE-and rhoE-lacZ expression and created additional EOCs in leg discs when these clones were located close to an endogenous source of Dpp and Wg, respectively (Fig 4I, 4M, 4K and 4O ). However, when cis-regulation of EGFR activation in Drosophila melanogaster leg these clones were also mutant for Dll, these pathways were not able to activate either vnE or rhoE, and hence EGFR signaling (Fig 4J, 4N, 4L and 4P ).
Dissection of vnE and rhoE molecular inputs
Our genetic analysis suggests a complex interplay between the signaling pathways Wg and Dpp and the transcription factors Dll and Sp1 on the vnE and rhoE enhancers. To investigate the configuration of binding sites and the transcription factor grammar of these CRMs, we searched for putative binding motifs using available position weighted matrices (PWMs) [35] and computational methods for identifying consensus Pan (downstream effector of Wg signaling), Mad (downstream effector of Dpp signaling), Dll and Sp1 binding motifs [36] . We cis-regulation of EGFR activation in Drosophila melanogaster leg performed a comprehensive in vivo mutagenesis analysis for both enhancers (Fig 5A) . We mutagenized the enhancer elements by progressively adding (one at a time) mutations (S3 Table) in putative binding sites for each transcription factor (Fig 5A) , starting with those that best match consensus binding sites and proceeding to more degenerate binding sites. Because the information from the enhancer bashing experiments (Fig 1B and 1G ; S1 Table) revealed that parts of the enhancers containing multiple sites for each of the TFs can not drive intact expression patterns, we inferred that only having the full set of binding sites gives full expression patterns. Based on the combined analysis between the mutagenesis and the enhancer bashing data we found that there are a large number of binding sites important for vnE activation-14 Pan binding sites, 12 Mad sites, and 11 Dll sites (Figs 5A, 5B, 5D, S4A and S4B); mutagenesis of subsets of these binding sites leads only to reduction of enhancer-driven expression (S4A and S4B Fig) . In contrast, for each TF, there were fewer binding sites important for rhoE activation-4 Pan, 3 Mad and a single Dll binding site (Fig 5A, 5C and 5E ). Curiously, in the case of Dll we found 5 additional putative sites in rhoE that were not required for enhancer activity in optimal laboratory conditions (S4E and S4F Fig; S3 Table) . In general, the identified binding sites for the two enhancers had an additive effect on the expression levels of vnE and rhoE because partially mutated enhancers drove patchy expression and progressively diminished levels of reporter expression (S4A, S4B, S4C and S4D Fig) . We also confirmed the binding of the TFs involved in vnE and rhoE regulation by in vitro binding assays, suggesting that they act directly to regulate these enhancers (Fig 5F) . It is striking that vnE contains many more binding sites for each TF compared to rhoE. In addition to the differential requirement for Sp1, this difference may also contribute to the earlier timing of vnE activation compared to rhoE, because the larger number of binding sites might render vnE more sensitive to lower TF concentrations.
Consistent with the genetic requirement for Sp1, we identified two putative Sp1 binding sites in vnE. However, when we mutagenized them reporter gene expression was unaltered (Fig 5B and 5D) . Therefore, we scanned the enhancer by EMSA using overlapping fragments (S2 Table) in order to identify additional Sp1 binding sites in an unbiased manner. We found that Sp1 binds with low affinity to some Mad binding sites (Fig 5F) . Because both Sp1 and Mad can bind to some of the same binding sites, loss of vnE-lacZ expression when Mad sites are mutated may be a consequence of eliminating all Mad and some of the Sp1 inputs.
Because Sp1 and Dll are co-expressed during leg development, we also scanned all of vnE using overlapping oligos (S2 Table) to determine if these proteins might bind cooperatively to DNA. For these experiments we used full-length Dll and nearly full-length Sp1 proteins (see Materials and Methods). Although these experiments confirmed Dll binding to its binding sites, we failed to detect any cooperative binding between Dll and Sp1. Taken together, our results suggest that Sp1 regulates vnE through two Sp1 binding sites and some shared binding sites with Mad.
The vnE and rhoE regulatory logic is widely used among leg CRMs
The vnE and rhoE regulatory inputs that we discovered here resemble one previously characterized in DllLT [9] , in that they are all activated by the combinatorial input of Wg, Dpp, Dll and/ or Sp1 [5] . These findings prompted us to test if there might be a battery of CRMs that is regulated in the leg disc by these same inputs. To test this idea, we first determined the genome-wide in vivo binding profiles of Dll and Sp1 using chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) in third instar leg discs (Fig 6A) . We used either anti-Dll antibody or anti-GFP antibody to ChIP an Sp1-GFP fusion protein expressed from an engineered~80 kb BAC construct (see Materials and Methods) that drives Sp1-GFP expression identically to Sp1, and can rescue an Sp1 null mutant. Here we focus on genomic loci that show an intersection between 1) Sp1 and Dll binding events, 2) putative Dll, Sp1, Mad and Pan binding sites, and 3) have accessible chromatin as revealed by FAIRE-seq data for leg discs [37] . We found 442 genomic regions that satisfy all six criteria, many of which were close to genes that are expressed in leg discs (S4 Table) . In addition, two regions correspond to vnE and Dll M , another previously defined CRM of Dll (Fig 6C and 6G ). As expected, rhoE was not identified because there was no consensus Sp1 binding site in rhoE. However, this approach identified a fragment that is within rhoLLE1 (rhoLLE1
MIN
) that, when tested in a reporter gene, drove expression in similar ring pattern as rhoLLE1 (Fig 6E) .
To validate the larger set of predicted CRMs, we picked 20 additional genomic fragments (23 together with vnE, Dll M and rhoLL1
,~5% of the total 442 intersections) near 11 genes [Antennapedia (Antp), four-jointed (fj), spitz (spi), disconnected (disco), tarsal-less (tal), spineless (ss), Zn finger homeodomain 2 (zfh2), elbow B (elB), no-ocelli (noc), Enhancer of split m3 (E(spl) m3-HLH), and Distal-less (Dll)]. Using this approach, we discovered at least one leg disc enhancer element with a PD bias for each of the genes we tested (Figs 6 and S5; S5 Table) , except for disco. In some cases (Antp, fj, spi, Dll, noc) multiple fragments generated leg disc expression patterns. Interestingly, we uncovered two leg disc enhancers for the EGFR ligand Spi. Overall, 18 of the 23 tested fragments (78%) are leg enhancers, suggesting that there is a battery of leg disc gene CRMs that drive expression differentially along the leg disc PD axis and are regulated by the direct input of Wg, Dpp, Dll and Sp1.
We also used genome-wide intersection criteria that excluded Sp1 as a factor, thus following the rhoE regulatory logic. Not surprisingly, this dataset was much larger (3809 loci), making it difficult to validate experimentally. Nevertheless, it also seems to predict enhancer loci because, in addition to rhoE, some of the identified regions corresponded to previously identified leg CRMs such as Dll DKO [38] , Dll LL [39] , and enhancer elements identified in genome-wide tiling studies [40] .
Discussion
Multiple sources of short-range EGFR signaling during fly leg development
The EGFR signaling pathway is widely used in animal development, and is frequently a target in human disease and developmental abnormalities [reviewed in 41] . Yet despite its importance in animal biology, many questions remain about how this pathway functions. Among these questions is whether secreted ligands that activate this pathway can induce distinct cell fates in a concentration-dependent manner. Here, we test this idea by specifically eliminating a single source of EGFR ligands from the center of the Drosophila leg imaginal disc, which fate maps to the distal-most region of the adult leg. One plausible scenario is that this single source Putative binding sites for each TF were mutagenized one at a time leading to progressive increase in the number of mutant binding sites until the expression driven by a mutant enhancer was lost. Sites in each TF category that were mutagenized either first or last are not sufficient for full enhancer-driven expression since fragments of vnE and rhoE (Fig 1B and 1G ; S1 Table) cis-regulation of EGFR activation in Drosophila melanogaster leg of secreted EGFR ligands, which we refer to as the EOC, activates distinct gene expression responses at different distances from this source. Alternatively, eliminating ligands secreted from the EOC might only affect gene expression locally, close to or within the EOC. Taken together, our data are most consistent with the second scenario (Fig 7) . This conclusion is cis-regulation of EGFR activation in Drosophila melanogaster leg largely supported by our observations that CRM deletions that eliminate vn and rho expression from the EOC have mild developmental consequences, both in the L3 leg imaginal discs and adult legs. These phenotypes are significantly weaker than those generated when the entire EGFR pathway is compromised using a temperature sensitive allele of the EGFR receptor. The difference between these two phenotypes is most likely explained by removing only a single source of EGFR ligands in the enhancer deletion experiments versus affecting EGFR signaling throughout the leg disc in the Egfr tsla experiments. This explanation is further supported by our observation that there are indeed additional CRMs, some of which we define here, that drive EGFR ligand production in more medial ring-like patterns during the L3 stage. One possible caveat to these conclusions is that there are a total of seven rho-like protease genes in the Drosophila genome that could, in principle, play a role in distal leg development. We focused on rho and ru, based on previous results [11, 14] showing that triple rho ru vn clones generate severe leg truncations that phenocopy strong Egfr tsla truncations. In addition,
we note that if other rho family proteases were active in the EOC, we would not expect to see cis-regulation of EGFR activation in Drosophila melanogaster leg leg truncations and patterning defects in the leg discs of the rho rhoE-Df vn vnE-Df double mutant, because those proteases should be able to produce active Spi. These observations suggest that the remaining five rho-like protease genes play a minor (or no) role in leg development. However, this conclusion will ultimately benefit from further genetic and expression analysis of these additional rho-like genes. An additional previous observation that contrasts with the suggestion that EOC activity has only a limited role in specifying distal leg fates is the partial rescue of the PD axis when only a small number of distal leg cells were wild type in legs containing large rho ru vn clones [11] . However, we note that even in these 'rescued' legs, medial defects in PD patterning were apparent. It is also noteworthy that in these earlier experiments, only adult legs were examined. When we repeated the same experiment, but analyzed L3 discs, we found that rho ru vn clones generated phenotypes that were very similar to those produced by our double vnE rhoE enhancer deletions. Taken together, these observations suggest that timing must be considered in the interpretation of these experiments. When assayed at the late L3 stage, both our enhancer deletion and rho ru vn clone experiments argue that EOC activity is limited to specifying only the most distal fates, marked by the expression of al and C15. Starting in mid L3, and perhaps continuing into pupal development, there are additional sources of EGFR ligands [14] that, when compromised, can affect adult leg morphology. Nevertheless, at least at the L3 stage, these data suggest that EGFR ligands produced from the EOC have a limited and local role in specifying distal leg fates (Fig 7) .
cis-regulatory networks during leg development
Integration of inputs from signaling pathways and organ selector genes at CRMs in order to execute distinct developmental programs is a recurrent theme during animal development (reviewed in [42] ). Here, we identified two leg EGFR ligand CRMs that integrate the inputs from the Wg and Dpp signaling pathways and the leg selector genes Dll and/or Sp1 in a manner that is very similar to a previously characterized leg enhancer DllLT [9] . In addition, when we applied the same regulatory logic to the whole genome, we identified a battery of leg enhancer elements (Fig 6) . Interestingly, each of these enhancers drives expression in a specific manner with slightly different timing despite the fact that many of the inputs are shared. It is conceivable that the different expression patterns directed by these enhancers are in part a consequence of additional inputs and/or the difference in the TF binding site grammar. In support of this idea, vnE and rhoE differ in the number of binding sites for many inputs and vnE requires Sp1 while rhoE does not. Both of these differences may contribute to the earlier onset of vnE expression compared to rhoE. The remaining enhancer elements identified in this study direct a plethora of PD-biased leg expression patterns-ranging from ubiquitous, to central and 'ring' patterns (Fig 6) , which likely integrate inputs in addition to the ones described here. Future studies of these CRMs would help reveal the complex network of regulation that orchestrates leg development in the fruit fly. Such detailed understanding of the cis-regulatory architecture of fly leg development would likely give insights into organogenesis and evolution in other animals as well.
cis-regulation of EGFR signaling and cancer
The EGFR signaling pathway has tremendous oncogenic potential and understanding the various mechanisms regulating its activation is not only interesting from the point of view of animal development but also has important practical implications. While the core components of the EGFR pathway have been thoroughly studied because of their potent tumorigenic capability in humans [reviewed in 43] , little is known about the transcriptional regulation of EGFR ligands that bind the receptor and activate the pathway. The reiterative use of EGFR signaling in many developmental processes implies that different cis-regulatory elements are likely utilized by each EGFR ligand in different organs and tissues in order to correctly read the diverse cues in any specific developmental context. It is conceivable that genomic variation in EGFR pathway CRMs might lead to a predisposition to different types of EGFR-dependent tumors in humans, since such CRMs may respond to potent growth-promoting signaling pathways, such as Wnt and BMP.
In this study, we characterized in detail two Drosophila EGFR CRMs, vnE and rhoE, and showed how they integrate the cues from two transcription factors, Dll and Sp1, and two signaling pathways, Wg and Dpp, in order to execute a leg patterning developmental program. Analogous EGFR CRMs are likely to exist in mammals, especially because complex interactions between BMP, Wnt, Shh, multiple Dlx paralogs and other factors, are implicated in the induction of FGF signaling in mammalian limb development. Consistent with this idea, specific single nucleotide polymorphisms (SNPs) in humans in non-coding loci of genes encoding EGFR ligands have been shown to be associated with different types of cancer [44] [45] [46] . Such loci may be enhancer elements analogous to vnE and rhoE. We also note that the regulatory logic uncovered here is likely to be relevant to many CRMs and genes that share spatial and temporal expression programs. Exploiting this regulatory logic in other systems might streamline the identification of enhancer elements that will aid in the discovery of mechanisms that are relevant to EGFR-related human disease and developmental birth defects.
Materials and methods
Drosophila genetics
The following mutant alleles and enhancer trap alleles were used in this study: arr ). For Flp-FRT inducible mitotic recombination and subsequent mosaic clonal analysis fly larvae were heat-shocked at 48h post egg laying (PEL), 72h PEL or 90h PEL and dissected for staining as crawling stage larvae at around 120h PEL. For generation of Flp-FRT mitotic recombination clones, larvae were heat-shocked for 40 minutes at 37˚C. Mitotic recombination clones were generated using the following strains: w hs-Flp 1.22 Ubi-RFP FRT19A, yw hs-Flp 1.22 ; Ubi-GFP FRT40A /CyO; E/TM6B, yw hs-Flp 1.22 ; FRT42D Ubi-GFP/CyO; E/TM6B, yw hs-Flp 1.22 ; E/CyO; Ubi-GFP FRT80B /TM6B, yw hs-Flp 1.22 ; E/CyO; FRT82B Ubi-GFP/TM6B, yw hs-Flp 1.22 ; FRT42D M-hs-GFP/CyO; E/TM6B, yw hs-Flp 1.22 ; E/CyO; Ubi-GFP M-FRT80B/TM6B. The corresponding strains carrying mutant alleles were used in crosses for generation of mutant clones in the resulting progeny. E in these genotypes designates either vnE-lacZ or rhoE-lacZ inserted in landing sites 51D or 86Fa on chromosome II and III, respectively. To induce GFP expression in larvae marked with hs-GFP, an additional heat-shock was given 1 h before dissection for 20 min to 1 hour at 37˚C.
The 
Plasmids and transgenes
All wildtype and mutagenized enhancer-reporter transgenic constructs were made using the lacZ reporter vector pRVV54 as an acceptor vector [49] . Coordinates of the genomic fragments PCRamplified in the enhancer bashing experiments are listed in S1 and S5 Tables. The FC31 system was used for transgenesis and plasmids were introduced in landing sites 51D or 86Fa [50] .
Site-directed mutagenesis of the vnE and rhoE enhancers was performed according to the QuikChange II protocol (Agilent Technologies). vnE and rhoE enhancers were first introduced in pBluescript SK+ vector for site-directed mutagenesis and the resulting mutated enhancers were consequently transferred to pRVV54 for in vivo analysis in the fruit fly. Primers used for mutagenizing of putative binding site are listed in S3 Table. Plasmids for recombinant protein production were made by introducing cDNA sequences into pET21 series vectors (Novagen-EMD Millipore) and their derivatives, resulting in C-terminally tagged His proteins. Primers used to generate Dll-His (full-length Dll), Sp1
Zn-finger -His (only the Zn-finger domains; used for confirming in vitro binding to Sp1 sites), Sp1 
CRISPR/Cas9 alleles
The vnE and rhoE CRISPR/Cas9 alleles were generated by using pCFD4 vector for driving gRNA expression [18] and a germline-expressing Cas9 donor strain for plasmid mix injection [19] . Table) .
Protein assays
Recombinant proteins were expressed in BL21 (DE3) cells (Agilent Technologies) through IPTG induction for 4h. Proteins were subsequently purified through Cobalt chromatography with TALON Metal Affinity Resin (Clontech, #635501). EMSA gels were performed as previously described [53] .
Immunohistochemistry and adult leg analysis
Immunostainings of fly imaginal discs was performed by standard protocol. The following antibodies were used in this study: rabbit anti-β-galactosidase (Cappel), mouse anti-β-galactosidase (Sigma-Aldrich, #G4644), guinea pig anti-Dll [9] , rat anti-Sp1, guinea pig anti-Hth [54] , mouse-anti-GFP (ThermoFisher Scientific, #A11121), rat anti-C15 [15] , rat anti-Al [6] , rat anti-BarH1 [55] , rabbit anti-BarH1 [56] , mouse anti-Dac [57] . AlexaFluor488-, AlexaFluor555-, and AlexaFluor647-conjugated secondary antibodies from ThermoFisher Scientific or Jackson ImmunoResearch Laboratories were used at 1:500 dilution. Adult legs were dissected, mounted, and analyzed by light microscopy. All adults of the relevant genotype that eclosed within an 8-hour period were scored. Roman numerals in the figure legends indicate the tarsal segments present in each phenotypic class (with the distal most segment perturbed). For example, a truncation designated as I-III means that tarsal segments I, II and III were present, with segment III partially defective (e.g. Fig 2P) . n refers to the number of individual legs scored. The number of legs examined for each genotype is reported in the figures and figure legends.
In situ hybridization
To generate vectors for in situ probes vn, ru, spi, Krn, and grk DNA sequences were amplified from genomic DNA and rho DNA sequence was amplified from cDNA clone (LD06131; DGRC clone #3528) using primers listed in S2 Table. DNA fragments were cloned into pBluescript SK+ (Agilent Technologies).
RNA antisense probes were transcribed with either T3 or T7 RNA polymerase (depending on the cDNA sequence orientation in the vectors listed in S2 Table) and labeled using DIG UTP mix (Sigma, #11175025910). Sense RNA probes were used as negative controls. rho probes were then hydrolized for 30 minutes at 60˚C as previously described [58] . Third instar larvae were dissected in cold 1xPBS and fixed for 16h at 4˚C in 4% PFA + 2mM EGTA. In situ hybridization was then performed as previously described [58] and signal was developed in BM-Purple AP substrate (Sigma #11442074001) after staining with anti-DIG -AP antibody at a concentration of 1:2000 (Roche #1093274). Multiple (!10) discs were examined for each time point, probe, and genotype.
Fluorescence quantification
Mid-third instar larvae carrying wild-type or mutant vnE-or rhoE-lacZ reporter constructs were raised, fixed, stained and imaged in parallel according to standard immunohistochemical protocols. Average fluorescence was measured for the area within the central/tarsal domain of all unobstructed leg imaginal discs using ImageJ software (http://rsb.info.nih.gov/ij) and reported as the ratio of β-gal:Dll (staining control) in arbitrary units (AU). Ordinary one-way ANOVA adjusted for multiple comparisons (Dunnett's test) were performed and graphed in Prism software (graphpad.com) to compare wild-type fluorescence to mutant enhancer genotypes where ns = not significant, Ã = p 0.0332, ÃÃ = p 0.0021, ÃÃÃ = p 0.0002 and ÃÃÃÃ = p<0.0001 (adjusted p-values). n refers to the number of individual leg discs scored. The number of leg discs scored for each genotype is reported in the figure legends.
Chromatin IPs
Triplicate pools of 100 yw and 100 Sp1-GFP BAC L3 wandering larvae were used to perform independent chromatin IPs as previously described [59] . The Sp1-GFP BAC is a GFP-tagged Sp1 in BAC clone CH321-64M02 inserted in landing site VK00033 (gift from Dr. Rebecca Spokony). All 6 leg discs from each larva were used as material for each IP. Chromatin from the yw larvae pools was immuno-precipitated with goat anti-Dll antibody (sc-15858, Santa Cruz Biotechnology, 1.5 μg/ml for IP) while chromatin from the Sp1-GFP BAC larvae pools was immuno-precipitated with rabbit anti-GFP antibody (ab290, Abcam, 1300 dilution for IP). DNA from non-immunoprecipitated 10% chromatin input was isolated from each pool as reference control. Both control and immunoprecipitated DNA samples were prepared for Illumina sequencing using the Epicentre Nextera DNA Sample Preparation Kit and sequenced on an Illumina HiSeq 2000 according to the manufacturer's specifications. Experiments were performed in duplicate and peak calling was based on merged reads for duplicate ChIPs. Sequences were aligned to the Drosophila genome using the Burrows-Wheeler Aligner and ChIP-seq peaks were called using MACSv2 [60, 61] . Peak regions were defined using a p-value cutoff of 1.00e-02, but only those peaks passing a more stringent q-value cutoff of 1.00e-04 were used for further analysis. Datasets generated in this study are available at the Gene Expression Omnibus (GEO): accession number GSE113574.
Bioinformatic intersection analysis
PWMs for Dll, Sp1, Pan, and Mad were extracted from The Fly Factor Survey Database using the command grep within the MotifDb Bioconductor/R package. To generate BED files containing position information for each of the above PWMs, the matchPWM command from the Biostrings Bioconductor/R package was used. In-house code was used to run the command iteratively through the chromosomes (using DM3 build). Only hits above a minimum score of 80% were retained. IGVtools within the Integrative Genomics Viewer (IGV) was used to sort and index the BED files prior to intersection. Intersections of all BED files (derived from PWM analysis and ChIP-seq and FAIRE peak calling analysis) were done using Bedtools2 run locally from the command line. ChIP-seq peaks for Dll and Sp1 were first intersected with the FAIRE peaks. The product of this intersection was then sequentially intersected with each of the PWM files, always returning the peak coordinates from the initial file. The command intersectBed was used with options: -wa, -F 1.0, -u. To determine the gene nearest to each of the intersected ChIP peaks, packages within R/Bioconductor were used. The annotation package TxDb.Dmelanogaster.UCSC.dm3.ensGene was downloaded and annotated transcripts extracted. The distanceToNearest function was used to find the nearest annotated transcript to each of the ChIP Peaks. In-house R script was then used to generate the table containing the coordinates of the ChIP peaks, as well as the nearest annotated gene (S4 Table) .
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